MedPath

DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP

DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP

Approved
DIN Number

00761826

Drug Class

Human

Market Date

Dec 31, 1990

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00761826
AIG Number0217918003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01CA04 DOPAMINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification12:12.08.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

DEXTROSEActive
Strength: 50 MG / ML
Monograph: DEXTROSE
DOPAMINE HYDROCHLORIDEActive
Strength: 1.6 MG / ML
Monograph: DOPAMINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.